OK, women of the world. Grab some paper and a pen and jot down this list of seven check-ups every woman needs. Don't just write them down, though. Make sure you take action on each and every one. They might just save your life.

1. Start with your weight, height, and BMI (body mass index). The scores you get on these simple tests are important because many conditions and diseases are associated with being overweight or underweight.

2. Check your blood pressure, and find out where you stand because hypertension is a disease with no symptoms. High blood pressure puts you at risk for cardiovascular disease -- but there are very effective treatments for this condition.

There is a new test that can identify potentially serious problems much earlier than the standard Pap smear, according to a recent large Danish study.

Think about this:

A new HPV test effectively checks women 40 and older for the virus that causes cervical cancer. The women who carry the virus are at significant risk for the disease and can truly benefit from this test. Women younger than 40 can still contract the virus but it tends to come and go and isn't as likely to lead to cancer. These under-40 women are sill better off receiving the standard Pap test, say researchers.

Source: Good Housekeeping, May 2007

Wouldn't it be great if we could find breast cancer long before something appears on a mammogram?

An FDA approved test called the Halo Breast Pap Test System might be able to do just that by collecting Nipple Aspirate Fluid (NAF). The test is designed to detect abnormal cells in the breast. The Halo system can identify benign disease as well as abnormal ductal cells that can be precursors to cancer.

Some research has suggested that ductal fluid excreted from the nipple can be used to identify a women's specific risk of breast cancer. A women with abnormal cells in the fluid has a four to five times greater risk of developing breast cancer.

Think about this:

The introduction of the HALO Breast Pap Test has been compared to the introduction of the Cervical Pap Test in the 1950s, which is widely credited with reducing cervical cancer death rates by more than 70 percent through the identification of abnormal cells in the cervix. Whether the same can be said for the breast pap test remains to be seen, but it is likely that the screen will be adopted by more OB-GYNs as oncologists push for ever earlier identification of cancer.

The FDA was given the okay by their panel of advisors to approve the drug Provenge, an immunotherapy that stimulates the immune system to help fight cancer cells.

The drug is designed for patients with metastatic prostate cancer who stop responding to hormonal therapy. The drug triggers the immune system to recognize a particular protein that is found on about 95 percent of all prostate cancer cells. When the immune system identifies the protein, it attacks the cancer cells.

The drug has shown in two previous trials that it increases survival in patients that have prostate cancer that has spread to other parts of the body.

Women in England are not showing up for their annual pap tests. And their absence from this critical screening opportunity is increasing their risk of cervical cancer -- a cancer that is curable if detected early.

New figures reveal that 660,000 women between the ages of 25 and 29 are invited for screening in England. Nearly 80 percent of these women accepted their invitations and reported for their tests in 1995 -- but only 69.4 percent did so last year. Women aged 30 to 34 are also down in attendance -- by about 800 women per week. Essentially, this means about 2,000 women each year who have pre-cancerous cells are missing the chance for early detection and diagnosis.

The Department of Health, now investigating the falling figures, attributes the decline to perhaps a not-so-successful screening program, discomfort about the procedure, or fear that the experience will be embarrassing.

United States drug company Merck hopes to offer the cervical cancer vaccine Gardasil to developing countries at much lower prices -- within months, if possible.

Currently, the three-dose vaccine is not affordable in the developing world -- where 80 percent of cervical cancer deaths occur and 95 percent of females have never had a Pap test . And while the exact discounted price has not yet been determined, Merck professionals report they are committed to slashing the price of Gardasil for these women.

Merck also aims to help developing countries receive drugs sooner. Right now, there is a time lag of 15 to 20 years between the approval of drugs in the West and the time they reach these countries.

Back in the summer of 2000, a year before I was diagnosed with breast cancer, I was told I had an abnormal pap smear. Cancerous and precancerous changes in the cervical cells are often first detected by the pap test. A sample of cells are removed from the cervix and then examined under a microscope. If the pap test does come back abnormal the physician will usually schedule a colposcopy. I was advised after my abnormal pap smear to go through this procedure. A colposcopy is when the doctor will use a microscope to better see the cervix and find abnormal cells that he can then remove and further evaluate. This procedure was not any more uncomfortable than a normal gynecological visit, except for the mild cramping afterward.

Unfortunately upon further evaluation I was diagnosed with cervical dysplasia which lead to me getting the LEEP procedure, loop electrosurgical excision procedure, an outpatient surgery. I was very scared since I had never been put under general anesthesia. I came out of the surgery and again all that happened was more cramping throughout the next few days. Since that time I have had normal pap smears and never miss my yearly appointment to get this test done.

A phase II clinical trial suggests that daily treatment of Celebrex (celecoxib) may effectively treat high-grade precancerous changes to the cervix. The results were published in the journal Gynecologic Oncology. Celebrex belongs to the class of drugs known as non-steroidal anti-inflammatory drugs. Researchers took 25 patients with high grade precancerous changes of the cervix and treated them with either Celebrex 200mg twice a day or a placebo.

The results showed that cervical abnormalities improved in 75 percent of patients treated with Celebrex and 31 percent of patients treated with the placebo. A complete disappearance of detectable cervical abnormalities was experienced by 33 percent of patients treated with Celebrex and 15 percent of patients treated with placebo.

The researchers conclude that Celebrex could offer a noninvasive approach to treating precancerous cervical changes. Larger studies are needed to confirm these findings.

Even though the LEEP procedure was not that terrible, it would have definitely been better to take a pill instead. I do hope this proves to be successful in the treatment of cervical dysplasia.

On Friday, I had my annual OB/GYN appointment. It's the appointment known by all women for (1) its blood pressure check and humbling weigh-in, (2) the pee-in-a-cup ritual, (3) the get naked and change-into-a-paper-dress routine, (4) the finger-stick-iron-check, (5) the clinical breast exam, (6) the manual internal pelvic exam, and (7) the ever popular feet-in-stirrups Pap test. It's all so uncomfortable, so not fun. Yet it's all so necessary.

It was a visit with my OB/GYN that resulted in my breast cancer diagnosis two years ago this month. It was the clinical breast exam that confirmed the hard little lump I had found in the shower the previous day. It's what prompted my emergency mammogram a day later. It's what sent me on the wildest ride of my life. It's what keeps me going back for repeat yearly visits -- because I know if something goes wrong with my female parts, this doctor is likely the one who will make the discovery. He is likely the one who will save me from a late diagnosis of something terrible, the doctor who will set the wheels in motion for whatever comes after something terrible is detected.

I know already that (1) my blood pressure and weight are normal, (2) my urine is normal, (3) the paper dress is so not flattering, (4) my iron is normal, (5) my breasts are normal, and (6) my ovaries and uterus feel normal. I am only waiting on (7) the results of my Pap test that will reveal any abnormalities in the tissue of my cervix. This is the one test that can save me from cervical cancer or detect the disease in a stage that is completely curable. It's one of the best cancer screening tests around -- and I plan to receive it every year, year after year -- even if I have not one ounce of modesty left when it's said and done.

It's not so bad really. I'm accustomed to the rituals of the annual exam. I know the drill, know I will survive it all, know it's all critical for maintaining my health. So it's good really. Good -- compared to what could happen if something went undiscovered.

Cervical cancer was once the most common cancer in women. But between 1955 and 1992, the number of cervical cancer deaths dropped by 74 percent -- thanks to increased use of the Pap test, a screening tool that can find changes in the cervix before cancer develops and can also detect cancer in its most curable stage. The Pap test is still widely used. And the cervical cancer death rate continues to drop four percent every year.

In 2006, about 9,700 new cases of invasive cervical cancer will be diagnosed in the United States. About 3,700 women will die from the disease. Non-invasive cervical cancer is believed to be four times more common than the invasive form of the disease. Nearly all of these cases can be cured.

Cervical cancer typically occurs in women between the ages of 35 and 55 and rarely in women under the age of 20. It affects mostly Hispanic women, and African-American women develop the disease 50 percent more often than non-Hispanic white women. Women most as risk for cervical cancer are smokers, those with HIV or chlamydia infections, those with diets low in fruit and vegetable consumption, those who between 1940 and 1971 took the hormonal drug DES, and those who have taken oral contraceptives for extended periods of time. Women who have had multiple pregnancies, have a family history of the disease, and have a low socio-economic status are also at risk. Those most at risk, however, are women with human papilloma virus.

Human papilloma virus (HPV) is the most common risk factor for cervical cancer, and some experts believe a woman must have HPV to contract cervical cancer. There are 100 different types of HPV, 13 of which are likely to cause cervical cancer through sexual contact. There are usually no symptoms of HPV, but possible signs of cervical cancer can include vaginal bleeding, unusual discharge, pelvic pain, and pain during sexual intercourse.

There are two ways to stop cervical cancer. First, women can protect themselves against HPV. Protection comes in the form of delaying sexual activity, limiting the amount of sexual partners and their partners, using condoms (thought to be 70 percent effective) and receiving the cervical cancer vaccine, recommended for use in females ages 11-26. The vaccine is most effective for women who have never been sexually active. Second, women can receive regular Pap tests in order to catch pre-cancers. Pap tests are recommended for women three years after their first sexual encounter and before the age of 21 -- and then every year after that.

An abnormal Pap test typically prompts a colposcopy -- a technique that uses a scope to examine the cervix. Diagnosis usually stems from a combination of other scoping methods, pelvic exams, imaging tests, and biopsies used to confirm the presence of cancer and to stage the disease. Stages range from 0-4.

For non-invasive cervical cancer, surgery -- ranging from removal of the cancerous tissue to hysterectomy -- may be the only treatment necessary. For invasive forms of the cancer, surgery is often followed by radiation and chemotherapy. Women interested in preserving their fertility should discuss options with their physicians.

The state of cervical cancer has come a long way over the years. And this year, two critical developments emerged. In June 2006, the FDA approved the first drug for late-stage cervical cancer. The drug, Hycamtin, is recommended for use in combination with chemotherapy. Also is June, the cervical cancer vaccine, Gardasil, was released. Both developments are monumental -- and both will undoubtedly help decrease the already-dropping cervical cancer death rate.

For more information about cervical cancer, visit the following sites:

American Cancer Society
Mayo Clinic
Medline Plus
National Women's Health Information Center

It can be hard to remember when it's time for check-ups and exams and screenings. Many come just once each year and with the swift passage of time, it's easy to forget our medical to-do lists. But missing an appointment -- or even delaying one -- can lead to missed and delayed diagnoses. So remembering these easy-to-forget chores is key. And perhaps reminders are the key to remembering.

The American Cancer Society offers a free mammogram reminder in the form of e-mail message sent each year to remind women to schedule their mammograms. It takes just a moment to register with an e-mail address and a preferred month and day of the year for this e-mail to arrive. To register for your yearly reminder, click here.

The College of American Pathologists offers a free reminder service for the following appointments -- blood donation, cholesterol screening, colon cancer screening, diabetes test, pap test, and mammogram. Click here to choose one or more of these options that also require just just an e-mail address and preferred month and date for delivery.

So forget that string around your finger -- reach for your computer keyboard right now. It takes just a few keystrokes to ensure prompt testing for the health issues that if detected early, can save our lives.

Right here in Gainesville, Florida -- at the University of Florida to be exact -- the vaccine for cervical cancer is now available for college students. This vaccine -- called Gardasil -- could prevent women from contracting the human papillomavirus (HPV) which can cause cervical cancer and genital warts. Almost 30 of the more than 100 different strains of HPV are sexually transmitted -- and sometime in their lives, 50 percent of sexually active men and women will contract genital HPV infection. Many will not know they have it and will spread it unknowingly to sexual partners. Protection can come in the form of Gardasil which is approved for use in women between the ages of 9 and 26.

Women who are not sexually active are the best candidates for this vaccine because it is clear that they have not yet been infected. The vaccine is not effective for women who already are infected with HPV. And those who don't know if they are infected can determine if they have HPV through a routine Pap smear. If they do not have HPV, the vaccine is indicated. Once the vaccine is indicated, it is delivered in three separate doses over a six-month period of time. Each dose costs $120 -- which may discourage students from this option.

About 9,700 women in the United States will develop cervical cancer in 2006 and this cancer will kill 3,700 of these women. This vaccine -- if received well by young women who can afford it -- should prove a breakthrough in cancer research and prevention.

I will share anything and everything about my own experience with breast cancer -- how I found it, how it was removed, how it was treated, how I fared through the whole ordeal, how I'm surviving now. I figure that if I spread the word about what happened to me, that others will become more aware and some -- especially those with a new diagnosis -- will benefit from whatever wisdom I have to impart. So I am an open book. I talk about breast cancer, answer questions about breast cancer, and probably insert my opinion about the topic to some who don't really care. But I will continue talking and sharing -- and writing -- because the alternative would be a disservice to the few I may be able to help.

So a card stuck in the middle of a magazine caught my eye the other day. The slogan on it reads, Tell Someone and the illustrations on this card -- that functions as a postcard -- show women reaching out to other women. There are women talking on the phone and a woman tapping another on the shoulder. The message they appear to be spreading is highlighted in the text below the graphic representation of this campaign to raise awareness of cervical cancer. The message is about HPV -- human papillomavirus -- and about how millions of women already have it and how some don't even know they have it. I learned from reading this card that for some, HPV will clear on its own. But for some, cervical cancer may develop. This is why Pap tests are critical. And so what all women should be telling other women is this -- ask your doctor about the importance of Pap tests. And be active in your own health. And follow all recommendations for detecting health concerns early. I learned from reading this card that I should tell someone about this. And so now I have.

The Lesbian Community Cancer Project (LCCP) in Chicago has partnered with Howard Brown Health Center to ensure that everyone in the LGBT community has access to free or sliding scale health services. Howard Brown offers free clinical breast exams, mammograms, and pap smears to all low-income, uninsured women and is one of twenty community health centers in Illinois that participates in an early screening program for breast and cervical cancer.

The Gildas Club in Chicago is now in collaboration with the Lesbian Community Cancer Project and a support group just for the LGBT community. Membership and participation in all activities is free and begins by calling (312) 464-9900. The LGBT Wellness Group and the LGBT Family and Friends Group meets every Thursday night from 6:00pm to 7:30pm at Gilda's Club Chicago located at 537 N. Wells Street.

The Gay and Lesbian Medical Association, (GLMA) researches and publishes facts that life habits and practices in gay males may make them more susceptible to cancer, heart disease, and other serious health problems. The GLMA works to ensure equality in health care for lesbian, gay, bisexual and transgender (LGBT) individuals and health care professionals.

Studies show that gay men use tobacco at much higher rates than straight men. Some studies show that statistic is almost 50 percent higher in gays than straight males. Tobacco-related health problems include lung disease and lung cancer, heart disease, high blood pressure, and more serious problems. Studies also show that gay men have higher rates of alcohol dependence and abuse than straight men and the use of substances like amyl nitrate poppers, marijuana, Ecstasy, and amphetamines which could cause serious consequences as they age are more prevalent in gay men. Alcohol consumption and smoking are also related to bladder cancers, colon cancers and others.

Some health professionals now recommend routine screening with anal Pap Smears, similar to the test done for women to detect early cancers. Gay men are at risk for, human papilloma virus, (HPV), that cause anal and genital warts. These infections play a role in the increased rates of anal and oral cancers in gay men.

Having the freedom and courage to discuss your lifestyle openly with your medical doctor is a must. Once that patient - professional relationship has comfortably been made, discussing these health concerns is the first step to maintaining your health.

In 2004, Women In Government launched its Challenge to Eliminate Cervical Cancer Campaign, to raise awareness about cervical cancer and human papillomavirus, HPV. The organization applauded the FDA approval of Gardasil, the first cervical cancer vaccine, for girls and women between the ages of 9 and 26. To guarantee that all girls and women have access to the new cervical cancer vaccine, they are urging the federal Advisory Committee on Immunization Practices to include the new cervical cancer vaccine in the federal government's Vaccines for Children Program, which provides free immunization for under-insured and uninsured children.

Women In Government president Susan Crosby stresses the continued importance of annual pap tests and screening in the early detection of cervical cancer caused by HPV in women who have already been exposed to the virus.